Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
about
Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cellsShc and Enigma are both required for mitogenic signaling by Ret/ptc2.Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascadePotent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinomaAssessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigationsDiagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.Thyroid cancer: current molecular perspectives.Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivoMouse models of endocrine tumours.Molecular approaches to thyroid cancer diagnosis.Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line.Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.Assessment of RET/PTC1 and RET/PTC3 rearrangements in fine-needle aspiration biopsy specimens collected from patients with Hashimoto's thyroiditis.BAC-FISH assays delineate complex chromosomal rearrangements in a case of post-Chernobyl childhood thyroid cancerHigh rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinomaLow VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma.RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR.Targeted treatment of differentiated and medullary thyroid cancer.New therapies for dedifferentiated papillary thyroid cancerSorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement.DNA copy number changes in thyroid carcinomaSympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)-transgenic miceRET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.Mouse models of follicular and papillary thyroid cancer progression.Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma.RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material.Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70New treatment in advanced thyroid cancer.Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity.Identification and characterization of RET fusions in advanced colorectal cancerPapillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.B-Raf mutation and papillary thyroid carcinoma patients.Personalizing therapy in advanced non-small cell lung cancerThyroid carcinoma: molecular pathways and therapeutic targetsWhat is New on Thyroid Cancer BiomarkersTranslocations in epithelial cancers.Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcriptsRET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis.
P2860
Q24314557-8B3803A5-EFEE-4499-AE77-71D4D158DB45Q24533621-2A5BB022-9C78-4954-BCFB-27A3B46776E8Q24550950-B48812D2-2FC0-4B5D-8700-3167133B18F6Q24669934-5E62E438-8071-48B4-BBF2-41C37175E31DQ31074050-1639072F-35EE-4B1C-9EAA-607C874DE99FQ31159590-8B542C17-DC49-4CCB-A57D-E2AEE8161D3AQ33624667-10D1CEE8-4BCD-476B-9339-82AFC198CD3BQ33760910-12EE2BE7-1B22-40F9-BE7E-BC6E28B72590Q33771043-A406B871-7B17-4628-9EE1-D2A7207B07EBQ34109756-EBC4D393-E3F9-4463-AE34-1DDA025DB587Q34129129-8BA79260-2866-43E9-A8B3-9799A837BA85Q34160828-9A1F6694-DB1F-40AC-8AE1-EDEE42563052Q34258443-7A909A6E-9853-4ABC-9AE4-C0D4E66FA43BQ34474368-DE08810B-D5D4-47F7-91C7-A57F55F6FFC3Q34504355-9101D035-ED32-4D5D-BF7C-9E46F0111F0BQ34550400-45EA2852-4BC7-4301-9291-B121F2DCDFD8Q34572289-0CEBA0B8-1ABC-46B2-8C87-125B9D3E3226Q34662980-A132DD11-BCDA-45C0-968A-E89DD68BF5B5Q35124840-44AFA608-381D-4305-8FB4-E416A03610DAQ35147151-4E8FBB27-A506-47BE-B76C-56ED529A2892Q35381593-E12AFDFD-3038-4177-857A-419FA2A242DAQ35570953-4A69C6C4-F454-4BBF-B992-C764325A549AQ35786903-7BE52220-200C-47A4-B441-6C07A7DEB072Q35787988-9CD18A93-4B4C-4A03-A011-59B8A609B332Q35971877-E109B386-AA69-4110-AEE3-00CD6D2BB1A6Q35971896-EDF68E91-5F21-4B64-9CE7-CCDBCC62169BQ35977327-70DA3078-05AA-4C70-BC4C-BCC0035407D5Q36135918-7CEDC25C-8E79-4543-813C-D8C0CDB5BFE4Q36357367-0401AD5C-2BE2-446E-864B-507563E57DDFQ36361115-04B63102-2EB6-46ED-8ADD-A226FAFBAF58Q36382025-9B72EA91-D653-4196-9F91-B07E53C3CF86Q36557174-169D6F96-8379-46AB-B22B-66B12121A241Q36623366-0DA4626F-9BD1-44A3-9A8C-7B5B0D055352Q36741221-60BB061F-8E6C-4849-8F71-F4119AE6452BQ36811453-227EE7AC-6244-4F52-A233-172E31E5C166Q37147768-F88095FA-4C16-4778-86BF-3D69931D8D67Q37207279-D7A3B78A-F69A-40F9-A1BA-EF2B13886C9DQ37363960-93330E16-DBEC-4286-996F-A4C7291AD96DQ37641177-5729AEA4-C7DE-4DB7-9097-7143D2699E3AQ37650677-2C0BBC6B-FE0A-43F7-BE8C-C858966671E8
P2860
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Molecular characterization of ...... n thyroid papillary carcinoma.
@ast
Molecular characterization of ...... n thyroid papillary carcinoma.
@en
Molecular characterization of ...... n thyroid papillary carcinoma.
@nl
type
label
Molecular characterization of ...... n thyroid papillary carcinoma.
@ast
Molecular characterization of ...... n thyroid papillary carcinoma.
@en
Molecular characterization of ...... n thyroid papillary carcinoma.
@nl
prefLabel
Molecular characterization of ...... n thyroid papillary carcinoma.
@ast
Molecular characterization of ...... n thyroid papillary carcinoma.
@en
Molecular characterization of ...... n thyroid papillary carcinoma.
@nl
P2093
P1433
P1476
Molecular characterization of ...... n thyroid papillary carcinoma.
@en
P2093
Berlingieri MT
Bongarzone I
Pierotti MA
P304
P407
P577
1994-02-01T00:00:00Z